These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3006296)

  • 1. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.
    Chunge CN; Gachihi G; Muigai R; Wasunna K; Rashid JR; Chulay JD; Anabwani G; Oster CN; Bryceson AD
    Trans R Soc Trop Med Hyg; 1985; 79(5):715-8. PubMed ID: 3006296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.
    Bryceson AD; Chulay JD; Mugambi M; Were JB; Gachihi G; Chunge CN; Muigai R; Bhatt SM; Ho M; Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(5):705-14. PubMed ID: 3006295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
    Rees PH; Kager PA; Wellde BT; Hockmeyer WT
    Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
    Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
    Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of allopurinol and pentostam in the treatment of visceral leishmaniasis.
    Tobaigy M; Mejer J; Peitersen B; Ansari M; Poll P
    Adv Exp Med Biol; 1986; 195 Pt A():471-3. PubMed ID: 3014837
    [No Abstract]   [Full Text] [Related]  

  • 6. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate.
    Chulay JD; Fawcett DW; Chunge CN
    Ann Trop Med Parasitol; 1985 Aug; 79(4):417-29. PubMed ID: 3000304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.
    Halim MA; Alfurayh O; Kalin ME; Dammas S; al-Eisa A; Damanhouri G
    Clin Infect Dis; 1993 Mar; 16(3):397-9. PubMed ID: 8135901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya.
    Chulay JD; Anzeze EM; Koech DK; Bryceson AD
    Trans R Soc Trop Med Hyg; 1983; 77(5):717-21. PubMed ID: 6318408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
    Thakur CP; Kumar M; Kumar P; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1557-61. PubMed ID: 2840172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis unresponsive to pentostam caused by Leishmania tropica in Kenya.
    Mebrahtu Y; Lawyer P; Githure J; Were JB; Muigai R; Hendricks L; Leeuwenburg J; Koech D; Roberts C
    Am J Trop Med Hyg; 1989 Sep; 41(3):289-94. PubMed ID: 2552850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate.
    Chunge CN; Owate J; Pamba HO; Donno L
    Trans R Soc Trop Med Hyg; 1990; 84(2):221-5. PubMed ID: 2167522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1987 Sep; 35(9):641-3. PubMed ID: 2830224
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
    Kar S; Kar K; Bhattacharya PK; Ghosh DK
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol in the treatment of visceral leishmaniasis.
    Kager PA; Rees PH; Wellde BT; Hockmeyer WT; Lyerly WH
    Trans R Soc Trop Med Hyg; 1981; 75(4):556-9. PubMed ID: 6275579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).
    Chulay JD; Spencer HC; Mugambi M
    Am J Trop Med Hyg; 1985 Jul; 34(4):702-9. PubMed ID: 2992303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.